Oct 2024 Articles

Articles
LDL-C and hs-CRP Jointly Modify the Effect of Lp(a) on 5-Year Death in Patients With Percutaneous Coronary Intervention
Li J, Yan K, Zhu P, et al.
Journal:
Clin Cardiol

First published: October 21, 2024 DOI: 10.1002/clc.70025
View
- Share
Articles
Real-World Exploration of LDL-Cholesterol Management in Patients with Atherosclerotic Cardiovascular Disease
Shah NP, Mulder H, Lydon B, et al.
Journal:
Am Heart J

First published: October 16, 2024 DOI: 10.1016/j.ahj.2024.10.009
View
- Share
Articles
Single bolus PCSK9 Inhibition: A new approach to plaque stabilisation
Nicholls SJ, Manmathan GP
Journal:
Atherosclerosis

First published: October 11, 2024 DOI: 10.1016/j.atherosclerosis.2024.118628
View
- Share
Articles
Short-Term Dual Antiplatelet Therapy After Drug-Eluting Stenting in Patients With Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis
Carvalho PEP, Gewehr DM, Nascimento BR, et al.
Journal:
JAMA Cardiol

First published: October 9, 2024 DOI: 10.1001/jamacardio.2024.3216
View
- Share
Articles
Influence of Subclinical Atherosclerosis Burden and Progression on Mortality
Fuster V, García-Álvarez A, Devesa A, et al.
Journal:
J Am Coll Cardiol

First published: October 8, 2024 DOI: 10.1016/j.jacc.2024.06.045
View
- Share
Articles
Within-person stability of lipoprotein(a) concentration
Ghouse J, Ahlberg G, Albertsen Rand S, et al.
Journal:
Eur Heart J

First published: October 8, 2024 DOI: 10.1093/eurheartj/ehae652
View
- Share
Articles
Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study
European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration (EAS FHSC)
Journal:
Lancet Diabetes Endocrinol

First published: October 3, 2024 DOI: 10.1016/S2213-8587(24)00221-3
View
- Share

Oct 2024 Articles

Articles

LDL-C and hs-CRP Jointly Modify the Effect of Lp(a) on 5-Year Death in Patients With Percutaneous Coronary Intervention

Li J, Yan K, Zhu P, et al.

Articles

Real-World Exploration of LDL-Cholesterol Management in Patients with Atherosclerotic Cardiovascular Disease

Shah NP, Mulder H, Lydon B, et al.

Articles

Single bolus PCSK9 Inhibition: A new approach to plaque stabilisation

Nicholls SJ, Manmathan GP

Articles

Short-Term Dual Antiplatelet Therapy After Drug-Eluting Stenting in Patients With Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis

Carvalho PEP, Gewehr DM, Nascimento BR, et al.

Articles

Influence of Subclinical Atherosclerosis Burden and Progression on Mortality

Fuster V, García-Álvarez A, Devesa A, et al.

Articles

Within-person stability of lipoprotein(a) concentration

Ghouse J, Ahlberg G, Albertsen Rand S, et al.

Articles

Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study

European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration (EAS FHSC)

Articles

LDL-C and hs-CRP Jointly Modify the Effect of Lp(a) on 5-Year Death in Patients With Percutaneous Coronary Intervention

Li J, Yan K, Zhu P, et al.

Share

Articles

Real-World Exploration of LDL-Cholesterol Management in Patients with Atherosclerotic Cardiovascular Disease

Shah NP, Mulder H, Lydon B, et al.

Share

Articles

Single bolus PCSK9 Inhibition: A new approach to plaque stabilisation

Nicholls SJ, Manmathan GP

Share

Articles

Short-Term Dual Antiplatelet Therapy After Drug-Eluting Stenting in Patients With Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis

Carvalho PEP, Gewehr DM, Nascimento BR, et al.

Share

Articles

Influence of Subclinical Atherosclerosis Burden and Progression on Mortality

Fuster V, García-Álvarez A, Devesa A, et al.

Share

Articles

Within-person stability of lipoprotein(a) concentration

Ghouse J, Ahlberg G, Albertsen Rand S, et al.

Share

Articles

Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study

European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration (EAS FHSC)

Share